These new medications, like copyright and Semaglutide, represent a significant class of drugs called GLP-1 receptor agonists. They work by stimulating the body's intrinsic ability to secrete GLP-1, a chemical that https://ztndz.com/story28404277/understanding-semaglutide-glp-1s